CCN2 and chronic obstructive pulmonary disease: The profibrotic responses occurring in the lungs of CSE-treated animals may result from the abnormal production/activation of growth factors, such as TGFβ/CTGF, which are reported to be increased in the lungs of patients with COPD [60].